Przejdź do zawartości
Merck

Is there a role for digoxin in atrial fibrillation without heart failure?

Cardiology journal (2009-09-16)
Julie Master, Paul Schweitzer
ABSTRAKT

Digoxin remains one of the most frequently prescribed drugs in the management of atrial fibrillation. The main indications for digoxin in atrial fibrillation are restoration of sinus rhythm, prevention of recurrence and slowing of the ventricular rate. However, none of these effects of digoxin have been confirmed in placebo controlled studies. In addition, recent reports suggest increased mortality in patients with atrial fibrillation without heart failure taking digoxin. The aim of this article is to review the role of digoxin in atrial fibrillation without heart failure.

MATERIAŁY
Numer produktu
Marka
Opis produktu

USP
Digoxin, United States Pharmacopeia (USP) Reference Standard
Digoxin, European Pharmacopoeia (EP) Reference Standard
Supelco
Digoxin, analytical standard
Supelco
Digoxin solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Digoxin for peak identification, European Pharmacopoeia (EP) Reference Standard